Evercore ISI lowered the firm’s price target on Ibotta (IBTA) to $32 from $38 and keeps an In Line rating on the shares following Q3 results that the firm calls “a mixed bag.” Revenue and EBITDA estimates for 2026 have been cut by 11% and 16%, respectively, reflecting ongoing concerns, notes the analyst, who adds that “transformation takes time.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBTA:
- Ibotta, Inc.: Buy Rating Affirmed Amid Growth Potential and Strategic Advancements
- Ibotta price target lowered to $22 from $24 at BofA
- Ibotta price target lowered to $23 from $26 at Goldman Sachs
- Ibotta, Inc. Class A: Hold Rating Amid Promising Initiatives and Macroeconomic Challenges
- Cautious Outlook for Ibotta, Inc. Amid Revenue Decline and Uncertain LiveLift Initiative